Find a TenderAwarded without competition
Published 5 Jan 2026, 13:28 GMT

Official UK procurement notice

Extension of agreement for the management of an informatics platform which allows access to UK Biobank data

Official notice

Authority: UK Biobank Ltd (Public body)

ServicesAward procedure without prior publication of a call for competition
Awarded value£11,000,0002 contracts · exc. VAT
Awarded 23 Jan 2026no call for competition
Awarded to DNAnexus Inc.2 awards

What is being bought

Published requirement description

UK Biobank ("UKB") has extended its contract with DNAnexus for the ongoing management and support of its the Research Analysis Platform (as described in section II.2.4) for a period of two years to allow UKB to conduct i) a procurement exercise in relation to the development of an Output Checking System, ii) preliminary market engagement and a procurement exercise for the provision of cloud infrastructure services to securely store and handle the UKB data once a new cloud-based Research Analysis Platform is established and iii) preliminary market engagement and a procurement exercise for the development of that new Research Analysis Platform.

The extension of the Research Analysis Platform contract was not the subject of a competitive procurement pursuant to the Public Contracts Regulations 2015 as amended or otherwise for the reasons set out in the voluntary ex ante transparency notice (reference 2026/S 000-000312) published on 5th January 2026 and in this notice.

CPV: Computer platforms · Computer-related services · Data services · Industry specific software package

The lotProcurement structure

single lot · no lot value published
Lot #1UKB currently hosts a cloud-based Research Analysis Platform which makes UKB data…Awarded

UKB currently hosts a cloud-based Research Analysis Platform which makes UKB data accessible to registered researchers within designated areas of the Research Analysis Platform, such that they can conduct their approved research project. The current Research Analysis Platform was procured by UKB in 2020. It was developed by DNAnexus, in collaboration with, and cloud infrastructure provided by, Amazon Web Services. At the end of Q2 2024 UKB adopted a Research Analysis Platform by default approach (with very limited exemptions), such that all UKB researchers were obliged to conduct their research on the Research Analysis Platform. The rationale behind this change is that the health record linkage data - both secondary and in due course primary - is now only permissible through a cloud-based environment (within the EEA). This significantly raised the level of adoption and usage of the Research Analysis Platform and required substantive improvements in functionality and scale to the Research Analysis Platform. As a consequence, the volume of researchers accessing the Research Analysis Platform has increased very significantly since it was first launched by UKB, with the number of researchers accessing data via the platform increasing from less than 50 in February 2021 to circa 16,500 in 2025.

UKB has extended its contract with DNAnexus for the ongoing management and support of the Research Analysis Platform for a period of two years to allow UKB to progress discrete but linked competitive procurement exercises in relation to the implementation of a secure data environment strategy which encompasses:

(i) the development of an Output Checking System (OCS) to improve the functionality and security of the UKB data and to facilitate the necessary certification by the Department of Health and Social Care (DHSC) and National Health Service (NHS) for the purposes of facilitating access to linked health record data and in particular the provision of the future primary care data;

(ii) the provision of cloud infrastructure for the storage and handling of growing volumes of UKB data and support proposed enhancements to the new Research Analysis Platform (see below); and

(iii) the development of a new Research Analysis Platform to provide a stable platform for research activities taking account of technology advancements over the past 5/6 years and incorporate new datasets to be accessed by researchers and make improvements to meta data storage and researcher tools.

On 23 April 2025, UKB issued Preliminary Market Engagement Notices in respect of the proposed procurements for the Output Checking System, cloud infrastructure and the new Research Analysis Platform. These Preliminary Market Engagement Notices were updated on 10 December 2025. These noted the inter-related nature of the three procurements and the intention to carry out the procurements for the Output Checking System and cloud infrastructure in advance of (and in order to inform) the procurement for the development of the new cloud infrastructure and Research Analysis Platform. As such, UKB intends to conduct the procurement of the Output Checking System first, in the first half of 2026, followed (in the second half of 2026 or early 2027) by the procurement of cloud infrastructure services that will apply once the new Research Analysis Platform is in operation and finally the conduct of the procurement for the new Research Analysis Platform in 2027. UKB intends to undertake preliminary market engagement in relation to the cloud infrastructure (to understand how storage capacity and compute optimisation can enhance the functionality and security of UKB's data) and in relation to the new Research Analysis Platform (to understand the needs of its researchers and the solutions which may be available on the market) before launch of the respective procurement exercises. This strategy and sequencing of the procurement exercises will facilitate a smooth transition - for UKB's many thousands of researchers - to an enhanced secure environment for the access and use of the critical UKB data and research projects.

The need for the Output Checking System was only made explicit in 2024 when the DHSC and NHS communicated the need for UKB to have certification in order to continue to receive and make available linked health record data and to be able to incorporate primary care data into UKB datasets. It is necessary and appropriate for the procurement exercises for both the Output Checking System and for the cloud infrastructure which will host the data once the new platform is established to be completed before preliminary market engagement can take place with suppliers and users regarding the requirements and strategic approach to the new Research Analysis Platform. The Output Checking System and cloud infrastructure procurement exercises need to be completed before the competitive procurement exercise for the development of the new platform, on the basis that the outputs and associated infrastructure will inform the technology solution for the new platform. The Output Checking System will be delivered first to meet both UKB and government need to increase the security of data and subsequently allow for new datasets to be accessed securely by researchers. The delivery of the OCS will also allow UKB to further develop data storage and usage requirements that will inform the cloud infrastructure procurement as well as the future Research Analysis Platform. In light of the above, to facilitate the procurement of the new platform and ensure an orderly transition to that new platform, an extension to the contract with DNAnexus was required. There is no practical prospect of another contractor operating the current Research Analysis Platform due to the proprietary DNAnexus intellectual property rights in the platform software and UKB's licence to such rights only being available during the life of the DNAnexus contract.

UKB considered that the extension to the …

Delivery: UK

Procedure terms & legal framework

From the official record
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
5 Jan 2026, 13:28 GMT
Last source update
26 Jan 2026, 17:02 GMT
FTS notice number
2026/S 000-006837
Classification (CPV)
Computer platformsComputer-related servicesData servicesIndustry specific software package
Delivery area
UK
Official registry OCID
ocds-h6vhtk-05ff59 Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

The original contract was the subject of a competitive procurement and was originally awarded to DNAnexus in 2020. The extension to the contract was permitted by Regulation 72 of PCR and in any event the direct award of a new contract for the ongoing management of the current platform until June 2028 would have been permitted under section 41 and paragraphs 5 and/or 6 and/or 7 of Schedule 5 to the Procurement Act 2023.

As highlighted in Section II.2.4, UKB considered that the extension of the agreement to support and manage the current Research Analysis Platform was permitted under regulation 72(1)(e) and 72(8) of the PCR. The extension to the contract with DNAnexus is for a period of two years until the proposed competitive procurement exercises in relation to the Output Checking System, the provision of cloud infrastructure services to support the new managed platform and the development and operation of the new platform have been completed. The position of DHSC and NHS in relation to the secure egress of data from the Research Analysis Platform could not have been foreseen until 2024. The sequencing of the procurement for the development of the Output Checking System and cloud infrastructure services logically precede the procurement of the new platform, as the choice of the new platform(s) will be dependent on the cloud technology which will host the data and take account of the Output Checking System. Clarity regarding these technical solutions is necessary to ensure certainty and transparency of requirements in relation to the platform to take account of new technologies and an orderly transition to a new secure data environment whereby the researchers can access wider subsets of UKB data.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 2
Awarded value £11,000,0002 contracts exc. VAT
Bids received 1
Contracts signed 2latest 23 Jan 2026
Awarded toValueDateStatus
DNAnexus Inc.£4,800,000 †—Awarded
DNAnexus Inc.£6,200,000 †—Awarded

Contracts

  • Contract 006837-2026-1 · DNAnexus Inc.

    Signed
    23 Jan 2026
    Value
    £6,200,000
    Status
    active
  • Contract 000312-2026-1 · DNAnexus Inc.

    Signed
    5 Jan 2026
    Value
    £4,800,000
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids———

Contracting authority & participating public bodies

UK BIOBANK LIMITED

Contracting authorityPublic bodyBody governed by public lawHealth GB-COH: 4978912 Units 1 & 2 Spectrum Way,, Stockport, North West, SK30SAContact email

Dispute resolution & review bodies

  • High CourtReview body London

Bidders & participating suppliers

1 commercial party on the notice
  • DNAnexus Inc.Awarded supplier 1975 West El Camino Real Suite 204 California, Mountain View, US, CA 94040

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.